Full Results From Moderna's Coronavirus Vaccine Study Will Take 2 Years, at Least
Moderna (NASDAQ: MRNA) plans to start a phase 3 clinical trial testing its mRNA-1273 coronavirus vaccine candidate in less than two weeks. But don't expect a quick turnaround of full study results. Moderna plans to follow patients for 759 days.
That's over two years.
Add in a month or two (or three or four) to enroll all 30,000 patients and a couple of months to crunch all the numbers after the study is completed, and it could be 2023 before we'll know if mRNA-1273 actually protects people from getting COVID-19.
Source Fool.com